These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31639396)

  • 1. Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.
    Ou-Yang F; Pan MR; Chang SJ; Wu CC; Fang SY; Li CL; Hou MF; Luo CW
    Life Sci; 2019 Dec; 238():116963. PubMed ID: 31639396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.
    Luo CW; Wu CC; Chang SJ; Chang TM; Chen TY; Chai CY; Chang CL; Hou MF; Pan MR
    Exp Cell Res; 2018 Feb; 363(1):65-72. PubMed ID: 29305962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
    Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
    Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer.
    Yin HL; Wu CC; Lin CH; Chai CY; Hou MF; Chang SJ; Tsai HP; Hung WC; Pan MR; Luo CW
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.
    Choi C; Kwon J; Lim S; Helfman DM
    Oncotarget; 2016 Sep; 7(39):63466-63487. PubMed ID: 27563827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition.
    Xiao G; Lu W; Yuan J; Liu Z; Wang P; Fan H
    J Transl Med; 2024 Jan; 22(1):99. PubMed ID: 38268032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of cancerous progression by LISCH7 via direct stimulation of TGFB1 transcription in triple-negative breast cancer.
    Tang X; Zhou Y; Liu Y; Zhang W; Liu C; Yan C
    J Cell Biochem; 2020 Nov; 121(11):4642-4653. PubMed ID: 32048750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
    Sheng J; Xue X; Jiang K
    Curr Mol Med; 2019; 19(2):147-155. PubMed ID: 30854965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
    Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
    Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
    Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling combined with functional analysis identify integrin beta1 (ITGB1) as a potential prognosis biomarker in triple negative breast cancer.
    Klahan S; Huang WC; Chang CM; Wong HS; Huang CC; Wu MS; Lin YC; Lu HF; Hou MF; Chang WC
    Pharmacol Res; 2016 Feb; 104():31-7. PubMed ID: 26675717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type X collagen knockdown inactivate ITGB1/PI3K/AKT to suppress chronic unpredictable mild stress-stimulated triple-negative breast cancer progression.
    Liu J; Chai XX; Qiu XR; Sun WJ; Tian YL; Guo WH; Yin DC; Zhang CY
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):133074. PubMed ID: 38866293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer.
    Huang YH; Chu PY; Chen JL; Huang CT; Huang CC; Tsai YF; Wang YL; Lien PJ; Tseng LM; Liu CY
    Sci Rep; 2021 Jun; 11(1):12171. PubMed ID: 34108545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer.
    Bhardwaj A; Singh H; Rajapakshe K; Tachibana K; Ganesan N; Pan Y; Gunaratne PH; Coarfa C; Bedrosian I
    Oncotarget; 2017 Mar; 8(12):19645-19660. PubMed ID: 28160548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,4-Methylenedioxy-β-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing β1 integrin function and surface protein disulfide isomerase.
    Chen IH; Chang FR; Wu YC; Kung PH; Wu CC
    Biochimie; 2015 Mar; 110():81-92. PubMed ID: 25593085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling in triple negative breast cancer is associated with metastasis.
    Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
    BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast Cancer.
    Ginter PS; McIntire PJ; Cui X; Irshaid L; Liu Y; Chen Z; Shin SJ
    Clin Breast Cancer; 2017 Nov; 17(7):544-549. PubMed ID: 28410844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.
    Hamurcu Z; Delibaşı N; Geçene S; Şener EF; Dönmez-Altuntaş H; Özkul Y; Canatan H; Ozpolat B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):415-430. PubMed ID: 29288363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.